Insider holders · CIK 0001759425
Mirum Pharmaceuticals, Inc. · MIRM
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Christopher PeetzCHIEF EXECUTIVE OFFICER | 194,440 | 187,500 | 381,940 | Sep 3, 2026 · 6:52 pm EDT | Form 4 |
| Peter RadovichPRESIDENT AND COO | 57,260 | — | 57,260 | Jun 8, 2026 · 4:27 pm EDT | Form 4 |
| Eric BjerkholtCHIEF FINANCIAL OFFICER | 44,745 | — | 44,745 | Sep 15, 2026 · 4:10 pm EDT | Form 4 |
| Jolanda HoweSVP, GLOBAL CONTROLLER | 616 | — | 616 | Sep 3, 2026 · 6:54 pm EDT | Form 4 |
| Robert Paul MyersChief Medical Officer | 55 | — | 55 | Sep 22, 2026 · 9:50 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.